India, Nepal, Bangladesh, and Sri Lanka Radiotherapy Market Size, Share, and Trends Analysis Report –Industry Trends and Forecast to 2031

India, Nepal, Bangladesh, and Sri Lanka Radiotherapy Market Analysis

The India, Nepal, Bangladesh, and Sri Lanka radiotherapy market is experiencing significant growth, driven by the growing steadily, fueled by increasing cancer prevalence and advancements in technology. Government initiatives and private investments in healthcare infrastructure contribute to market expansion. The technological advancements, such as the adoption of IMRT (Intensity-Modulated Radiation Therapy) and IGRT (Image-Guided Radiation Therapy) and increasing availability of cancer treatment centers, both public and private also drives the growth of market.

India, Nepal, Bangladesh, and Sri Lanka Radiotherapy Market Size

India, Nepal, Bangladesh, and Sri Lanka radiotherapy market size was valued at USD 116.75 million in 2023 and is projected to reach USD 273. 09 million by 2031, with a CAGR of 12.9% during the forecast period of 2024 to 2031. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include import export analysis, production capacity overview, production consumption analysis, price trend analysis, climate change scenario, supply chain analysis, value chain analysis, raw material/consumables overview, vendor selection criteria, PESTLE Analysis, Porter Analysis, and regulatory framework.

India, Nepal, Bangladesh, and Sri Lanka Radiotherapy Market Trends

“Growing Prevalence of Cancer Disease”

The incidence of cancer continues to rise due to factors such as aging populations, lifestyle changes, environmental factors, and increased cancer awareness and screening. The demand for effective treatment options such as radiotherapy grows as more individuals are diagnosed with cancer. Radiotherapy can be used as a primary treatment for cancer, especially in cases where surgery is not feasible or as effective. It can also be used in conjunction with surgery, chemotherapy, or immunotherapy to enhance treatment outcomes. The versatility of radiotherapy makes it an essential tool in the comprehensive cancer treatment arsenal.

Statistics on cancer describe that large groups of people have cancer across the world. Statistics show things that many people died from cancer each year. The treatment of radiotherapy can cure cancer symptoms.

In 2022, according to an article published in the National Library of Medicine, the number of cases of cancer in India was estimated to be 14,61,427. In India, one in nine people are likely to develop cancer in his/her lifetime.

According to a ResearchGate publication, Bangladesh recorded 156,775 cancer cases in 2020, representing 0.10% of the total population, with 108,990 resulting in fatalities, equivalent to 0.07% of the population (Fig. 1). Cervical cancer ranks as the second most prevalent cancer among women in Bangladesh, with 8,068 reported cases and 5,214 deaths. On a global scale, it is the fourth most common cancer affecting women

Report Scope and India, Nepal, Bangladesh, and Sri Lanka Radiotherapy Market Segmentation

India, Nepal, Bangladesh, and Sri Lanka Radiotherapy Market Definition

Radiotherapy is a type of treatment procedure that is mainly used for the treatment of cancer disease by the usage of X-rays along with similar forms of radiation technology. In radiotherapy treatment, high-energy-based radiation rays are often used to damage cancer cells and stop them from growing and dividing. Various types of software such as treatment planning software, dosage planning software, patient positioning software, image guiding software, and systemic radiotherapy among others are used in radiotherapy treatment planning. The treatment software program is used to calculate the dose of radiation which will be delivered to the patient's tumor and the surrounding normal tissue.                   

India, Nepal, Bangladesh, and Sri Lanka Radiotherapy Market Dynamics

Drivers  

• Novel Technology in Radiotherapy for Cancer Treatment

During the past several years, cancer radiotherapy has been largely driven by technological development. The technological development in radiotherapy is mainly focused on improving therapy procedures and launching new products which have advanced features that help in the treatment of cancer patients. This special issue aims at novel technological developments and has large potential in improving patient safety and treatment outcome in the radiotherapy management of cancers worldwide. Radiotherapy technology is one of the treatment lines for cancer disease. The procedure of radiotherapy involves, a higher dose of radiation delivered in the targeted cells through ionizing radiation, which causing causes the destruction of the cells and ceases their growth. The continuously increasing technology in radiotherapy is increasing the demand for radiotherapy for cancer treatment, due to which novel technology in radiotherapy for cancer treatment is propelling the demand of the market.

For Instance,

In October 2024, Aster DM Healthcare, one of India’s largest integrated healthcare providers, became the first facility in the country to implement Intra-Operative Electron Radiation Therapy (IOeRT), establishing a new standard in cancer treatment. This cutting-edge service is now available at the Aster International Institute of Oncology (AIIO) within Aster Whitefield Hospital, Bengaluru, marking a significant advancement in the hospital’s commitment to delivering high-quality cancer care. IOeRT, an innovative radiotherapy technique, delivers concentrated radiation directly to the tumor site during surgery, minimizing the need for multiple post-operative radiation sessions and protecting healthy tissue from unnecessary exposure. By targeting residual microscopic cancer cells immediately after tumor removal, IOeRT enhances treatment success rates and improves patient outcomes and recovery times.     

• Growing Demand for Radiotherapy in Diagnostics and Clinical Use

Radiotherapy have become essential in helping to diagnose organs and treat pathological disorders. They are utilized in diagnostic imaging and radiotherapy. Diagnostic radiopharmaceuticals possess no pharmacological effects and their administration is also not considered to be associated with relevant clinical side effects. The number of radiotherapy in clinical use is rapidly growing, thus, allowing the medical community better access to detail information on the characteristics of the different types of tumors. Radionuclides are also gaining importance by providing palliative and curative treatment for an increasing number of malignant diseases.

For instance,

According to a 2023 newsletter by Express Healthcare, precision radiation therapy is making significant strides in transforming cancer treatment in India. While traditional radiation therapy remains a key treatment option, the adoption of precision radiation therapy is steadily increasing due to its advantages in treatment accuracy, reduced side effects, and improved patient outcomes. Precision radiation therapy is particularly valuable in addressing the complexity and heterogeneity of cancer tumors. By precisely targeting cancer cells while minimizing damage to surrounding healthy tissue, this approach enhances treatment efficacy and reduces complications, leading to better patient outcomes. The choice of treatment, however, depends on factors such as tumor type, stage, location, patient health, and the availability of advanced technology at the treatment facility. After the era of cobalt-60, LINACs (Linear Accelerators) have become standard in most industrialized countries, delivering advanced techniques such as 3D CRT, IMRT, IGRT, and VMAT/RapidArc. These systems utilize real-time imaging for enhanced precision. IMRT and IGRT have introduced the concept of focal localized therapy, where stereotactic radiation therapy can be used to target small volumes with high precision. This method often allows for the delivery of high, ablative doses in one to five sessions, producing a steep dose fall-off outside the target area, minimizing harm to surrounding tissues.

Opportunities

• Increasing Healthcare Expenditure for Cancer Treatment

The government is continuously engaged in the activity of improving healthcare facilities to provide better health facilities and treatment to the patients such as improving cancer treatment procedures and increasing the number of radiotherapy treatment providers, among others. Growing healthcare expenditure is an opportunity for the market, because if investment in healthcare increases more people are getting aware of cancer disease and undergo advanced technology-based cancer treatment. Continuously increasing healthcare expenditure help the end user to install the latest technology-based radiotherapy systems to improve efficiency, accuracy, and number of successful radiotherapy cancer treatments. Increasing healthcare expenditure for cancer treatment also helps patients to take hassle-free advanced treatment for fast recovery. The spending on health is made up of the combination of out-of-pocket payments (people paying for their care), government expenditure, and sources including health insurance and activities by non-governmental organizations, this increasing healthcare expenditure for cancer treatment is acting as an opportunity to grow the demand of the market.

For instance,

According to the Economic Survey 2023-24, Prataprao Jadhav, Minister of State in the Union Ministry of Health and Family Welfare, informed the Lok Sabha that government health expenditure increased from 1.28% of GDP in 2018-19 to 1.9% in 2023-24

• Growing Government Initiatives Toward Cancer Treatment

The government plays a major role while taking initiative for the cancer diseases as cancer is a leading disease across the world. Government plays an important role to enhance the awareness of people undergoing appropriate cancer treatment. The government is actively engaged in taking several initiatives towards cancer treatment to increase awareness among the people regarding cancer disease. Government and Nongovernment organization are engaged in providing several types of funding for better treatment and increasing awareness for undergoes with radiotherapy, due to which growing government initiatives towards cancer treatment is boosting the demand of the market.

For instance,

Ayushman Bharat's radiotherapy coverage includes definitive, adjuvant, neo-adjuvant, and palliative treatments using advanced techniques such as Intensity Modulated Radiotherapy (IMRT) and Image Guided Radiotherapy (IGRT) for nearly all cancer sites

The National Cancer Grid (NCG) is an initiative of the Government of India through the Department of Atomic Energy and its grant-in-aid institution, the Tata Memorial Centre, to create a network of cancer centers, research institutes, patient groups, and charitable institutions across India to develop uniform standards of patient care for prevention, diagnosis, and treatment of cancer; providing specialized training and education in oncology and facilitating collaborative basic, translational and clinical research in cancer. NCG today has over 270 hospitals in its network across India.

Restraints/Challenges

• Strict Regulations and Standards for Approval and Commercialization of Radiotherapy Products

Radiotherapy products are one of the most expensive and complex types of medical devices. The stringent standards and regulations for the commercialization of radiotherapy products in the market are to be a big challenge for the manufacturers of radiotherapy products in the market. Every country has its own rules and regulations and has different bodies for the regulatory procedures of commercialization of products in the market. In the radiotherapy markets, various types of therapy products and treatment -Assisted Software are used, and the manufacturers have to follow regulatory guidelines for the manufacturing process. The regulatory authority any time recalls the product when they notice that the product is not up to the mark.

For instance,

In January 2019, according to an article published in Intricacies in the Approval of Radiopharmaceuticals – Regulatory Perspectives and the Way Forward, the premier agency governing radiopharmaceuticals and their regulations in India is the Atomic Energy Regulatory Board (AERB) under the Department of Atomic Energy (DAE), Government of India (GoI). It is the regulatory and safety monitoring authority for radiopharmaceuticals in the country

The regulatory requirement for approvals of marketing declaration of conformity and the time required for regulatory review may vary for different products. Different country has different regulatory body; manufacturing company has to fulfil all the requirement of a different country for commercializing products into the market. Manufacturers first have to take approval from the authority to launch their product into the market.

• Risk of Radiation Exposure 

In the radiotherapy power full radiation is used, this exposure of radiation is a measure of the ionization of air due to ionizing radiation from photons. The patients were suffering from various types of side effects due to this radiation exposure.

For instance,

Side effects depend on the type and location of radiation therapy, if the radiation therapy target at a patient's head or neck may cause below side effects:

• Dry mouth
• Mouth and gum sores
• Difficulty swallowing
• Stiffness in the jaw
• Nausea
• Hair loss
• A type of swelling called lymphedema

Very high levels of radiation can cause acute health effects which is very harmful to a patient’s health. In radiotherapy high powerful radiation exposure common side effects of radiation therapy include skin problems dryness, itching, blistering, and peeling among others The side effects of radiation exposure is depends on which part of the body received radiation therapy, for this reason, the risk of radiation exposure is expected to challenge the market growth.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

India, Nepal, Bangladesh, and Sri Lanka Radiotherapy Market Scope

The market is segmented on the basis of products & services, type, application, distribution channel, and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product & Services

• Services
• Product
  • External beam radiotherapy
    • Linac
    • Proton therapy
      • Synchroton
      • Cyclotron
    • Cyber knife
    • Gamma knife
    • Others
  • Internal radiation therapy
    • Seeds
    • Electronic brachytherapy
    • Applicators
    • Afterloaders
    • Others
  • Systemic radiotherapy/radiopharmaceuticals
    • Alpha emitters
    • Beta emitters
    • Others
• Software
  • Image guiding software
  • Treatment planning software
  • Patient positioning software
  • Dosage planning software
  • Others      

Type

• External-beam radiation therapy
  • Image-guided radiation therapy (IGRT)
  • Proton beam therapy
  • Stereotactic radiation therapy
  • Intensity modulated radiation therapy (IMRT)
  • Three-dimensional conformal radiation therapy (3d-crt)
  • Volumetric modulated arc therapy (VMAT)
  • Others
• Internal radiation therapy
  • Brachytherapy
  • Intraoperative radiation therapy (IORT)

Application

• Breast cancer
• Lung cancer
• Prostate cancer
• Colorectal cancer
• Lymphoma
• Liver cancer
• Thyroid cancer
• Brain cancer
• Cervical cancer
• Spine cancer
• Others

End User

• Hospitals
• Radiation therapy centers
• Specialty clinics
• Others

Distribution Channel

• Direct Tenders
• Third Party
• Others

India, Nepal, Bangladesh, and Sri Lanka Radiotherapy Market Regional Analysis

The market is analyzed and market size insights and trends are provided by country, products & services, type, application, distribution channel, and end user as referenced above.

The countries covered in the market are India, Nepal, Bangladesh, and Sri Lanka.

India is expected to be the fastest and dominating country in the the market due to the region's well-established livestock industry, high adoption of advanced reproductive technologies, availability of skilled veterinary professionals, and strong support from government and private initiatives aimed at improving animal productivity and genetic quality.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

India, Nepal, Bangladesh, and Sri Lanka Radiotherapy Market Share

The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.

India, Nepal, Bangladesh, and Sri Lanka Radiotherapy Market Leaders Operating in the Market Are:

• Elekta (Sweden)
• General Electric Company (U.S.)
• CANON MEDICAL SYSTEMS CORPORATION (Japan)
• Hitachi, Ltd. (Japan)
• Siemens Healthcare GmbH (Germany)
• Koninklijke Philips N.V. (Netherlands)

Latest Developments in India, Nepal, Bangladesh, and Sri Lanka Radiotherapy Market

• In  October 2021, General Electric Company presented innovative multi-modality radiation therapy solutions which are designed to improve patient-centered care and advance the practice of precision medicine. Through this presentation, the company has strengthened its role as a core partner in cancer treatment and diagnosis
• In June 2020, CANON MEDICAL SYSTEMS CORPORATION partnered with leading Russian healthcare provider R-pharm for maintenance and sales of diagnostic imaging equipment. Through this partnership, the company has boosted the overall company’s revenue
• In May 2020, Hitachi, LTD. announced that they have installed their first advanced proton therapy system at the Clínica Universidad de Navarra (Madrid, Spain). Clínica Universidad de Navarra is the first hospital where Hitachi installed the whole proton therapy system. After this announcement company enhanced its business and generated adequate revenue
• In May 2020, Elekta AB (PUB) announced that they have launched their new product Leksell Gamma Knife which is a next-generation treatment optimizer for intracranial stereotactic radiosurgery. After launching a new product company enhanced its product portfolio and generates adequate revenue

SKU-73036